Concepedia

C R Johnson

CR

3

Publications

332

Citations

3

H-Index

1998

Active since

Affiliations

Virginia Commonwealth University Medical Center(Current)

C R Johnson is an author at Virginia Commonwealth University Medical Center specializing in cell death, cancer research, and radiation oncology.

Top concepts

MedicineApoptosisCell DeathCancer ResearchRadiation OncologyOncologyCell BiologyPharmacologyCancer TherapyMedicinal Chemistry

Publications per year

1998–1999

3

Publications

3

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

J A Vrana, Roy H. Decker, C R Johnson et al. · Oncogene · 1999 · 286 citations

Hematological Malignancy, Suberoylanilide Hydroxamic Acid, Medicine +9

Evidence That the Apoptotic Actions of Etoposide Are Independent of c-Jun/Activating Protein-1-Mediated Transregulation

W. David Jarvis, C R Johnson, Frank A. Fornari et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 25 citations

BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effectsin vitro andin vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases

Dean G. Tang, Li Li, Zhenyu Zhu et al. · Pathology & Oncology Research · 1998 · 21 citations

Medicinal Chemistry, Reactive Oxygen Species, Medicine +9

Rows per page

1–3 of 3